Page 247 - E-book การประชุมวิชาการครั้งที่ 36
P. 247

11.  Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, et al. Screening for
                  pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet

                  Gynecol 2018;52:186-95.

                         12.  Wright D, Gallo DM, Pugliese SG, Casanova C, Nicolaides KH. Contingent screening for
                  preterm pre-eclampsia. Ultrasound Obstet Gynecol 2016;47:554-9.

                         13.  Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH. Competing-risks model in

                  screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at

                  11–13 weeks’ gestation. Ultrasound Obstet Gynecol 2017;50:589-95.
                         14.  Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, Matallana CP, et al. Aspirin

                  versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017;377:613-22.

                         15.  Magee LA, Dadelszen PV, Stones WM. The FIGO textbook of pregnancy hypertension.
                  An evidence-based guide to monitoring, prevention and management. London: The global library

                  of woman’s medicine; 2016.

                         16.  Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low- dose aspirin for prevention
                  of complications in pregnancy. Chronobiol Int 2013;30:260-79.

                         17.  Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, et al. Aspirin for

                  evidence- based preeclampsia prevention trial: Influence of compliance on beneficial effect of
                  aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol 2017;217:685.e1-685.e5.

                         18.  Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term
                  preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2018;218:287-93e1.

                         19.  Hofmeyr  GJ,  Lawrie  TA,  Atallah  AN,  Torloni  MR.  Calcium  supplementation  during

                  pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst
                  Rev 2018;10:CD001059.

                         20.  Okunsanya BO, Oladapo OT, Long Q, Lumbiganon P, Carroli G, Qureshi Z, et al. Clinical

                  pharmacokinetic properties of magnesium sulphate in women with preeclampsia and eclampsia.
                  BJOG 2016;123:356-6.












                 Management of Hypertensive Disorders in Pregnancy                                          231
   242   243   244   245   246   247   248   249   250   251   252